Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
Obagi Medical, a subsidiary of Waldencast plc (NASDAQ: WALD), has launched two new skincare products: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate. These innovations expand the ELASTIDERM® collection, offering transformative results for skin appearance and texture.
The Lift Up & Sculpt Facial Moisturizer, priced at $135, uses the patented Bi-Mineral Contour Complex™ to support skin elasticity and target aging signs. It also includes Polyglutamic Acid for intense hydration. The Advanced Filler Concentrate, priced at $115, contains Acetyl Hexapeptide-1 to re-plump and smooth wrinkles.
Both products will be available through professional channels and on Obagi.com from September 23rd. They are designed to complement in-office procedures and offer effective alternatives for those seeking anti-aging solutions outside clinical settings.
Obagi Medical, una filiale di Waldencast plc (NASDAQ: WALD), ha lanciato due nuovi prodotti per la cura della pelle: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer e ELASTIDERM® Advanced Filler Concentrate. Queste innovazioni espandono la collezione ELASTIDERM®, offrendo risultati trasformativi per l'aspetto e la texture della pelle.
Il Lift Up & Sculpt Facial Moisturizer, al prezzo di 135$, utilizza il complesso brevettato Bi-Mineral Contour Complex™ per supportare l'elasticità della pelle e mirare ai segni di invecchiamento. Include anche acido poliglutammico per una idratazione intensa. L'Advanced Filler Concentrate, al prezzo di 115$, contiene Acetyl Hexapeptide-1 per rimpolpare e levigare le rughe.
Entrambi i prodotti saranno disponibili attraverso canali professionali e su Obagi.com a partire dal 23 settembre. Sono progettati per completare le procedure in studio e offrire alternative efficaci per coloro che cercano soluzioni anti-invecchiamento al di fuori delle impostazioni cliniche.
Obagi Medical, una subsidiaria de Waldencast plc (NASDAQ: WALD), ha lanzado dos nuevos productos para el cuidado de la piel: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer y ELASTIDERM® Advanced Filler Concentrate. Estas innovaciones amplían la colección ELASTIDERM®, ofreciendo resultados transformadores para la apariencia y textura de la piel.
El Lift Up & Sculpt Facial Moisturizer, con un precio de 135$, utiliza el complejo patentado Bi-Mineral Contour Complex™ para apoyar la elasticidad de la piel y abordar los signos de envejecimiento. También incluye ácido poliglutámico para una hidratación intensa. El Advanced Filler Concentrate, al precio de 115$, contiene Acetyl Hexapeptide-1 para rellenar y suavizar las arrugas.
Ambos productos estarán disponibles a través de canales profesionales y en Obagi.com a partir del 23 de septiembre. Están diseñados para complementar los procedimientos en consulta y ofrecer alternativas efectivas para quienes buscan soluciones anti-envejecimiento fuera de entornos clínicos.
오바지 메디컬(Obagi Medical)은 월든캐스트(Waldencast plc)(NASDAQ: WALD)의 자회사로서 두 가지 새로운 스킨케어 제품을 출시했습니다: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer와 ELASTIDERM® Advanced Filler Concentrate. 이러한 혁신은 ELASTIDERM® 컬렉션을 확장하여 피부의 외관과 질감에 변혁적인 결과를 제공합니다.
Lift Up & Sculpt Facial Moisturizer는 135달러로 가격이 책정되며, 피부의 탄력을 지원하고 노화의 징후에 타겟팅하기 위해 특허받은 Bi-Mineral Contour Complex™를 사용합니다. 또한 강력한 수분 공급을 위해 폴리글루탐산도 포함되어 있습니다. Advanced Filler Concentrate는 115달러로 가격이 책정되며, 주름을 재충전하고 부드럽게 하는 Acetyl Hexapeptide-1를 포함하고 있습니다.
두 제품은 9월 23일부터 전문 채널과 Obagi.com에서 구매할 수 있습니다. 이러한 제품은 사무실 내 시술을 보완하도록 설계되었으며, 임상 환경 외부에서 노화 방지 솔루션을 찾는 사람들을 위한 효과적인 대안을 제공합니다.
Obagi Medical, une filiale de Waldencast plc (NASDAQ: WALD), a lancé deux nouveaux produits de soin de la peau : ELASTIDERM® Lift Up & Sculpt Facial Moisturizer et ELASTIDERM® Advanced Filler Concentrate. Ces innovations élargissent la collection ELASTIDERM®, offrant des résultats transformateurs pour l'apparence et la texture de la peau.
Le Lift Up & Sculpt Facial Moisturizer, au prix de 135$, utilise le complexe Bi-Mineral Contour Complex™ breveté pour soutenir l'élasticité de la peau et cibler les signes du vieillissement. Il contient également de l'acide polyglutamique pour une hydratation intense. L'Advanced Filler Concentrate, au prix de 115$, contient de l'Acetyl Hexapeptide-1 pour repulper et lisser les rides.
Les deux produits seront disponibles via des canaux professionnels et sur Obagi.com à partir du 23 septembre. Ils sont conçus pour compléter les procédures en cabinet et offrir des alternatives efficaces pour ceux qui recherchent des solutions anti-âge en dehors des environnements cliniques.
Obagi Medical, eine Tochtergesellschaft von Waldencast plc (NASDAQ: WALD), hat zwei neue Hautpflegeprodukte auf den Markt gebracht: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer und ELASTIDERM® Advanced Filler Concentrate. Diese Innovationen erweitern die ELASTIDERM®-Kollektion und bieten transformative Ergebnisse für das Aussehen und die Textur der Haut.
Der Lift Up & Sculpt Facial Moisturizer, der 135$ kostet, nutzt das patentierte Bi-Mineral Contour Complex™, um die Hautelastizität zu unterstützen und Alterszeichen gezielt zu bekämpfen. Er enthält außerdem Polyglutaminsäure für intensive Feuchtigkeit. Der Advanced Filler Concentrate kostet 115$ und enthält Acetyl Hexapeptide-1, um Falten aufzupolstern und zu glätten.
Beide Produkte sind ab dem 23. September über professionelle Kanäle und auf Obagi.com erhältlich. Sie sind so konzipiert, dass sie in-office Verfahren ergänzen und effektive Alternativen für diejenigen bieten, die Anti-Aging-Lösungen außerhalb klinischer Umgebungen suchen.
- Launch of two new innovative skincare products expanding the ELASTIDERM® collection
- Products incorporate advanced technology and patented formulations
- Clinically proven results in improving skin appearance and texture
- Designed to complement professional anti-aging treatments
- None.
Insights
The launch of Obagi Medical's new ELASTIDERM® products represents a strategic move in the high-end skincare market. With a
The incorporation of proprietary technology like the Bi-Mineral Contour Complex™ suggests a strong focus on innovation, which could potentially strengthen Obagi's market position. However, the distribution channel through professional partners and Obagi.com may impact initial sales volume. The delayed availability to general consumers until September 23rd could create anticipation but might also limit immediate revenue impact.
While this launch could boost Waldencast's skincare portfolio, its overall financial impact may be in the short term due to the niche market and distribution strategy. Investors should monitor how these products perform in driving growth within Obagi's professional channel and their potential to expand the company's consumer base.
Obagi's new ELASTIDERM® products showcase significant advancements in topical anti-aging solutions. The Lift Up & Sculpt Facial Moisturizer's Bi-Mineral Contour Complex™, combining Zinc, Copper and Malonate, represents a novel approach to supporting skin elasticity. The inclusion of Polyglutamic Acid (PGA) is noteworthy, as it's known for superior hydration properties compared to hyaluronic acid.
The Advanced Filler Concentrate's use of Acetyl Hexapeptide-1 is particularly interesting. This peptide has shown promise in mimicking the effects of botulinum toxin, potentially offering a non-invasive alternative for wrinkle reduction. However, it's important to note that while these products may complement clinical treatments, they cannot fully replicate the results of injectable or surgical procedures.
The clinical testing mentioned is positive, but without published peer-reviewed studies, it's difficult to fully assess the products' efficacy. The 6-week visible improvement claim is promising but relatively short-term in the context of skin aging. Long-term studies would provide more compelling evidence of sustained benefits.
These New Products are the Latest Innovation to Obagi’s ELASTIDERM® Collection
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation and pioneer in medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), proudly announces the launch of two groundbreaking skincare products: ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate. Both products deliver transformative results, leveraging cutting-edge technology and advanced formulations to enhance skin appearance and texture.
The ELASTIDERM® Lift Up & Sculpt Facial Moisturizer is clinically proven to visibly lift and sculpt facial contours. This advanced moisturizer actively supports skin's elasticity through Obagi's patented Bi-Mineral Contour Complex™, which combines Zinc, Copper, and Malonate to help support skin elasticity and target the signs of skin aging. It incorporates Polyglutamic Acid (PGA), a peptide known for its superior hydrating properties to provide intense hydration and help re-plump fine lines and wrinkles. The result is a visibly lifted, sculpted appearance with improved fullness, smoothness, and skin texture in just 6 weeks.*
The ELASTIDERM® Advanced Filler Concentrate offers a targeted solution for fine lines and wrinkles formulated with Acetyl Hexapeptide-1, an ingredient renowned for its effective re-plumping and wrinkle-smoothing benefits. The concentrate, applied topically with a precision applicator, delivers immediate filling effects for existing fine lines, while helping diminish wrinkles over time. This non-injectable solution is designed to provide a visibly lifted and youthful appearance by targeting emerging fine lines and wrinkles.*
Eman Kadhim, Head of Scientific Communications & Upstream Innovation at Waldencast, commented, “The release of the latest ELASTIDERM® products marks a notable advancement in dermatological research. These products incorporate our proprietary Bi-Mineral Contour Complex™ and Acetyl Hexapeptide-1, which were rigorously tested and proven effective in enhancing skin elasticity and hydration. These formulations enhance overall skin texture, underscoring our commitment to integrating cutting-edge scientific research and ingredients into practical, effective skincare solutions."
Justin Giouzepis, Chief Marketing Officer of Obagi Cosmeceuticals, added, “At Obagi, we are dedicated to supporting our valued physician and professional partners by providing products that enhance their anti-aging treatments. Our formulations are designed to complement in-office procedures, ensuring a comprehensive approach to skincare. Additionally, for those who seek transformative solutions for fine lines, wrinkles, and aging skin outside of clinical settings, the ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate products offer effective, high-quality alternatives to help them achieve their skincare goals."
ELASTIDERM® Lift Up & Sculpt Facial Moisturizer, priced at
*Results based on 2024 clinical tests. Data on file at Obagi Cosmeceuticals LLC.
About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, refined with a legacy of 35 years’ experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Backed by science and trusted by professionals, Obagi empowers individuals to achieve healthy, beautiful skin. More information about Obagi is available on the brand’s website, https://www.obagi.com.
About Waldencast
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.
Media Contact:
obagi@purplepr.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/798b5c0e-14fc-4953-a72e-1d23eb42fe26
https://www.globenewswire.com/NewsRoom/AttachmentNg/6add0355-4134-42d8-a887-81280d66262d
FAQ
What are the new products launched by Obagi Medical?
When will the new ELASTIDERM® products be available for purchase on Obagi.com?
What is the price of the ELASTIDERM® Lift Up & Sculpt Facial Moisturizer?
What is the main ingredient in the ELASTIDERM® Advanced Filler Concentrate?
